New trend in artificial intelligence-based assistive technology for thoracic imaging

The potential role of artificial intelligence to promote the participation and inclusion in physical exercise and sports for people with disabilities: A narrative review

The lack of physical activity presents a significant public health concern, particularly for individuals with disabilities who face heightened risks due to sedentary lifestyles. Despite progress, personal and environmental obstacles persist, hindering accessibility and full engagement in physical activities for people with disabilities, particularly children and adolescents. This narrative review highlighted the Artificial Intelligence (AI), in which emerges as a promising tool to address these challenges. By leveraging AI-powered assistive technologies, individuals with disabilities can overcome barriers, augment independence, and improve their overall quality of life. AI facilitates alternative communication avenues, enhances accessibility, and offers personalized exercise programs tailored to individual needs. Monitoring training metrics using AI systems provides valuable insights and feedback, promoting active participation and progress tracking. The dynamic relationship between AI and disability support continues to evolve, offering future opportunities for increased inclusivity and accessibility in sports and exercise environments.

Artificial intelligence in fracture detection on radiographs: a literature review

Fractures are one of the most common reasons of admission to emergency department affecting individuals of all ages and regions worldwide that can be misdiagnosed during radiologic examination. Accurate and timely diagnosis of fracture is crucial for patients, and artificial intelligence that uses algorithms to imitate human intelligence to aid or enhance human performs is a promising solution to address this issue. In the last few years, numerous commercially available algorithms have been developed to enhance radiology practice and a large number of studies apply artificial intelligence to fracture detection. Recent contributions in literature have described numerous advantages showing how artificial intelligence performs better than doctors who have less experience in interpreting musculoskeletal X-rays, and assisting radiologists increases diagnostic accuracy and sensitivity, improves efficiency, and reduces interpretation time. Furthermore, algorithms perform better when they are trained with big data on a wide range of fracture patterns and variants and can provide standardized fracture identification across different radiologist, thanks to the structured report. In this review article, we discuss the use of artificial intelligence in fracture identification and its benefits and disadvantages. We also discuss its current potential impact on the field of radiology and radiomics.

Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review

BACKGROUND

Pleural diseases represent a significant healthcare burden, affecting over 350 000 patients annually in the US alone and requiring accurate diagnostic approaches for optimal management. Traditional imaging techniques have limitations in differentiating various pleural disorders and invasive procedures are usually required for definitive diagnosis.

METHODS

We conducted a nonsystematic, narrative literature review aimed at describing the latest advances in imaging techniques and artificial intelligence (AI) applications in pleural diseases.

RESULTS

Novel ultrasound-based techniques, such as elastography and contrast-enhanced ultrasound, are described for their promising diagnostic accuracy in differentiating malignant from benign pleural lesions. Quantitative imaging techniques utilising pixel-density measurements to noninvasively distinguish exudative from transudative effusions are highlighted. AI algorithms, which have shown remarkable performance in pleural abnormality detection, malignant effusion characterisation and automated pleural fluid volume quantification, are also described. Finally, the role of deep-learning models in early complication detection and automated analysis of follow-up imaging studies is examined.

CONCLUSIONS

Advanced imaging techniques and AI applications show promise in the management and follow-up of pleural diseases, improving diagnostic accuracy and reducing the need for invasive procedures. However, larger prospective studies are needed for validation. The integration of AI-driven imaging analysis with molecular and genomic data offers potential for personalised therapeutic strategies, although challenges in data privacy, algorithm transparency and clinical validation persist. This comprehensive approach may revolutionise pleural disease management, enhancing patient outcomes through more accurate, noninvasive diagnostic strategies.

Smart nanomedicines powered by artificial intelligence: a breakthrough in lung cancer diagnosis and treatment

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to challenges in early detection, suboptimal therapeutic efficacy, and severe adverse effects associated with conventional treatments. The convergence of nanotechnology and artificial intelligence (AI) offers transformative potential in precision oncology, enabling innovative solutions for lung cancer diagnosis and therapy. Intelligent nanomedicines facilitate targeted drug delivery, enhanced imaging, and theranostic applications, while AI-driven models harness big biomedical data to optimize nanomedicine design, functionality, and clinical application. This review explores the synergistic integration of AI and nanotechnology in lung cancer care, highlighting recent advancements, key challenges, and future directions for clinical translation. Ethical considerations, including data standardization and privacy concerns, are also addressed, providing a comprehensive roadmap to overcome current barriers and advance the adoption of AI-driven intelligent nanomedicines in precision oncology. This synthesis underscores the critical role of emerging technologies in revolutionizing lung cancer management.

Integrating AI and Assistive Technologies in Healthcare: Insights from a Narrative Review of Reviews

The integration of artificial intelligence (AI) into assistive technologies is an emerging field with transformative potential, aimed at enhancing autonomy and quality of life for individuals with disabilities and aging populations. This overview of reviews, utilizing a standardized checklist and quality control procedures, examines recent advancements and future implications in this domain. The search for articles for the review was finalized by 15 December 2024. Nineteen review studies were selected through a systematic process identifying prevailing themes, opportunities, challenges, and recommendations regarding the integration of AI in assistive technologies. First, AI is increasingly central to improving mobility, healthcare diagnostics, and cognitive support, enabling personalized and adaptive solutions for users. The integration of AI into traditional assistive technologies, such as smart wheelchairs and exoskeletons, enhances their performance, creating more intuitive and responsive devices. Additionally, AI is improving the inclusion of children with autism spectrum disorders, promoting social interaction and cognitive development through innovative devices. The review also identifies significant opportunities and challenges. AI-powered assistive technologies offer enormous potential to increase independence, reduce reliance on external support, and improve communication for individuals with cognitive disorders. However, challenges such as personalization, digital literacy among the elderly, and privacy concerns in healthcare contexts need to be addressed. Notably, AI itself is expanding the concept of assistive technology, shifting from traditional tools to intelligent systems capable of learning and adapting to individual needs. This evolution represents a fundamental change in assistive technology, emphasizing dynamic, adaptive systems over static solutions. Finally, the study emphasizes the growing economic investment in this sector, forecasting significant market growth, with AI-driven assistive devices poised to transform the landscape. Despite challenges such as high development costs and regulatory hurdles, opportunities for innovation and affordability remain. This review underscores the importance of addressing challenges related to standardization, accessibility, and ethical considerations to ensure the successful integration of AI into assistive technologies, fostering greater inclusivity and improved quality of life for users globally.

Advancing clinical MRI exams with artificial intelligence: Japan's contributions and future prospects

In this narrative review, we review the applications of artificial intelligence (AI) into clinical magnetic resonance imaging (MRI) exams, with a particular focus on Japan's contributions to this field. In the first part of the review, we introduce the various applications of AI in optimizing different aspects of the MRI process, including scan protocols, patient preparation, image acquisition, image reconstruction, and postprocessing techniques. Additionally, we examine AI's growing influence in clinical decision-making, particularly in areas such as segmentation, radiation therapy planning, and reporting assistance. By emphasizing studies conducted in Japan, we highlight the nation's contributions to the advancement of AI in MRI. In the latter part of the review, we highlight the characteristics that make Japan a unique environment for the development and implementation of AI in MRI examinations. Japan's healthcare landscape is distinguished by several key factors that collectively create a fertile ground for AI research and development. Notably, Japan boasts one of the highest densities of MRI scanners per capita globally, ensuring widespread access to the exam. Japan's national health insurance system plays a pivotal role by providing MRI scans to all citizens irrespective of socioeconomic status, which facilitates the collection of inclusive and unbiased imaging data across a diverse population. Japan's extensive health screening programs, coupled with collaborative research initiatives like the Japan Medical Imaging Database (J-MID), enable the aggregation and sharing of large, high-quality datasets. With its technological expertise and healthcare infrastructure, Japan is well-positioned to make meaningful contributions to the MRI-AI domain. The collaborative efforts of researchers, clinicians, and technology experts, including those in Japan, will continue to advance the future of AI in clinical MRI, potentially leading to improvements in patient care and healthcare efficiency.

Contrast-enhanced thin-slice abdominal CT with super-resolution deep learning reconstruction technique: evaluation of image quality and visibility of anatomical structures

PURPOSE

To compare image quality and visibility of anatomical structures on contrast-enhanced thin-slice abdominal CT images reconstructed using super-resolution deep learning reconstruction (SR-DLR), deep learning-based reconstruction (DLR), and hybrid iterative reconstruction (HIR) algorithms.

MATERIALS AND METHODS

This retrospective study included 54 consecutive patients who underwent contrast-enhanced abdominal CT. Thin-slice images (0.5 mm thickness) were reconstructed using SR-DLR, DLR, and HIR. Objective image noise and contrast-to-noise ratio (CNR) for liver parenchyma relative to muscle were assessed. Two radiologists independently graded image quality using a 5-point rating scale for image noise, sharpness, artifact/blur, and overall image quality. They also graded the visibility of small vessels, main pancreatic duct, ureters, adrenal glands, and right adrenal vein on a 5-point scale.

RESULTS

SR-DLR yielded significantly lower objective image noise and higher CNR than DLR and HIR (P < .001). The visual scores of SR-DLR for image noise, sharpness, and overall image quality were significantly higher than those of DLR and HIR for both readers (P < .001). Both readers scored significantly higher on SR-DLR than on HIR for visibility for all structures (P < .01), and at least one reader scored significantly higher on SR-DLR than on DLR for visibility for all structures (P < .05).

CONCLUSION

SR-DLR reduced image noise and improved image quality of thin-slice abdominal CT images compared to HIR and DLR. This technique is expected to enable further detailed evaluation of small structures.

Recent topics in musculoskeletal imaging focused on clinical applications of AI: How should radiologists approach and use AI?

The advances in artificial intelligence (AI) technology in recent years have been remarkable, and the field of radiology is at the forefront of applying and implementing these technologies in daily clinical practice. Radiologists must keep up with this trend and continually update their knowledge. This narrative review discusses the application of artificial intelligence in the field of musculoskeletal imaging. For image generation, we focused on the clinical application of deep learning reconstruction and the recently emerging MRI-based cortical bone imaging. For automated diagnostic support, we provided an overview of qualitative diagnosis, including classifications essential for daily practice, and quantitative diagnosis, which can serve as imaging biomarkers for treatment decision making and prognosis prediction. Finally, we discussed current issues in the use of AI, the application of AI in the diagnosis of rare diseases, and the role of AI-based diagnostic imaging in preventive medicine as part of our outlook for the future.

AI Applications for Thoracic Imaging: Considerations for Best Practice

Artificial intelligence (AI) technology is rapidly being introduced into thoracic radiology practice. Current representative use cases for AI in thoracic imaging show cumulative evidence of effectiveness. These include AI assistance for reading chest radiographs and low-dose (1.5-mSv) chest CT scans for lung cancer screening and triaging pulmonary embolism on chest CT scans. Other potential use cases are also under investigation, including filtering out normal chest radiographs, monitoring reading errors, and automated opportunistic screening of nontarget diseases. However, implementing AI tools in daily practice requires establishing practical strategies. Practical AI implementation will require objective on-site performance evaluation, institutional information technology infrastructure integration, and postdeployment monitoring. Meanwhile, the remaining challenges of adopting AI technology need to be addressed. These challenges include educating radiologists and radiology trainees, alleviating liability risk, and addressing potential disparities due to the uneven distribution of data and AI technology. Finally, next-generation AI technology represented by large language models (LLMs), including multimodal models, which can interpret both text and images, is expected to innovate the current landscape of AI in thoracic radiology practice. These LLMs offer opportunities ranging from generating text reports from images to explaining examination results to patients. However, these models require more research into their feasibility and efficacy.

Applications of artificial intelligence in interventional oncology: An up-to-date review of the literature

Interventional oncology provides image-guided therapies, including transarterial tumor embolization and percutaneous tumor ablation, for malignant tumors in a minimally invasive manner. As in other medical fields, the application of artificial intelligence (AI) in interventional oncology has garnered significant attention. This narrative review describes the current state of AI applications in interventional oncology based on recent literature. A literature search revealed a rapid increase in the number of studies relevant to this topic recently. Investigators have attempted to use AI for various tasks, including automatic segmentation of organs, tumors, and treatment areas; treatment simulation; improvement of intraprocedural image quality; prediction of treatment outcomes; and detection of post-treatment recurrence. Among these, the AI-based prediction of treatment outcomes has been the most studied. Various deep and conventional machine learning algorithms have been proposed for these tasks. Radiomics has often been incorporated into prediction and detection models. Current literature suggests that AI is potentially useful in various aspects of interventional oncology, from treatment planning to post-treatment follow-up. However, most AI-based methods discussed in this review are still at the research stage, and few have been implemented in clinical practice. To achieve widespread adoption of AI technologies in interventional oncology procedures, further research on their reliability and clinical utility is necessary. Nevertheless, considering the rapid research progress in this field, various AI technologies will be integrated into interventional oncology practices in the near future.

Recent trends in scientific research in chest radiology: What to do or not to do? That is the critical question in research

Hereby inviting young rising stars in chest radiology in Japan for contributing what they are working currently, we would like to show the potentials and directions of the near future research trends in the research field. I will provide a reflection on my own research topics. At the end, we also would like to discuss on how to choose the themes and topics of research: What to do or not to do? We strongly believe it will stimulate and help investigators in the field.

All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement

Transcatheter arterial chemoembolization (TACE) is a proven and widely accepted treatment option for hepatocellular carcinoma and it is recommended as first-line non-curative therapy for BCLC B/intermediate HCC (preserved liver function, multifocal, no cancer-related symptoms) in patients without vascular involvement. Different types of TACE are available nowadays, including TAE, c-TACE, DEB-TACE, and DSM-TACE, but at present there is insufficient evidence to recommend one TACE technique over another and the choice is left to the operator. This review then aims to provide a comprehensive overview of the current literature on indications, types of procedures, safety, and efficacy of different TACE treatments.

SPE-YOLO: A deep learning model focusing on small pulmonary embolism detection

OBJECTIVES

By developing the deep learning model SPE-YOLO, the detection of small pulmonary embolism has been improved, leading to more accurate identification of this condition. This advancement aims to better serve medical diagnosis and treatment.

METHODS

This retrospective study analyzed images of 142 patients from Tianjin Medical University General Hospital using YOLOv8 as the foundational framework. Firstly, a small detection head P2 was added to better capture and identify small targets. Secondly, the SEAttention mechanism was integrated into the model to enhance focus on crucial features and optimize detection accuracy. Lastly, the feature extraction process was refined by introducing ODConv convolution to capture more comprehensive contextual information, thereby enhancing the detection performance of small pulmonary embolisms. The model's practical application ability was evaluated using 2000 cases from the RSNA dataset as an external test set.

RESULTS

In the Tianjin test set, our model achieved a precision of 84.20 % and an accuracy of 81.50 %. This represents an improvement of approximately 5 % and 4 % respectively compared to the original YOLOv8. F1 scores, recall rates and average accuracy have also increased by 4 %, 5 %, 6 %, respectively. In data from the external validation set of RSNA, SPE-YOLO exhibited its effectiveness with a sensitivity of 90.70 % and an accuracy of 86.45 %.

CONCLUSION

The SPE-YOLO algorithm demonstrates strong capability in identifying small pulmonary embolisms, offering clinicians a more accurate and efficient diagnostic tool. This advancement is expected to enhance the quality of pulmonary embolism diagnosis and support the progress of medical services.

Data set terminology of deep learning in medicine: a historical review and recommendation

Medicine and deep learning-based artificial intelligence (AI) engineering represent two distinct fields each with decades of published history. The current rapid convergence of deep learning and medicine has led to significant advancements, yet it has also introduced ambiguity regarding data set terms common to both fields, potentially leading to miscommunication and methodological discrepancies. This narrative review aims to give historical context for these terms, accentuate the importance of clarity when these terms are used in medical deep learning contexts, and offer solutions to mitigate misunderstandings by readers from either field. Through an examination of historical documents, including articles, writing guidelines, and textbooks, this review traces the divergent evolution of terms for data sets and their impact. Initially, the discordant interpretations of the word 'validation' in medical and AI contexts are explored. We then show that in the medical field as well, terms traditionally used in the deep learning domain are becoming more common, with the data for creating models referred to as the 'training set', the data for tuning of parameters referred to as the 'validation (or tuning) set', and the data for the evaluation of models as the 'test set'. Additionally, the test sets used for model evaluation are classified into internal (random splitting, cross-validation, and leave-one-out) sets and external (temporal and geographic) sets. This review then identifies often misunderstood terms and proposes pragmatic solutions to mitigate terminological confusion in the field of deep learning in medicine. We support the accurate and standardized description of these data sets and the explicit definition of data set splitting terminologies in each publication. These are crucial methods for demonstrating the robustness and generalizability of deep learning applications in medicine. This review aspires to enhance the precision of communication, thereby fostering more effective and transparent research methodologies in this interdisciplinary field.

Recent trends in AI applications for pelvic MRI: a comprehensive review

Magnetic resonance imaging (MRI) is an essential tool for evaluating pelvic disorders affecting the prostate, bladder, uterus, ovaries, and/or rectum. Since the diagnostic pathway of pelvic MRI can involve various complex procedures depending on the affected organ, the Reporting and Data System (RADS) is used to standardize image acquisition and interpretation. Artificial intelligence (AI), which encompasses machine learning and deep learning algorithms, has been integrated into both pelvic MRI and the RADS, particularly for prostate MRI. This review outlines recent developments in the use of AI in various stages of the pelvic MRI diagnostic pathway, including image acquisition, image reconstruction, organ and lesion segmentation, lesion detection and classification, and risk stratification, with special emphasis on recent trends in multi-center studies, which can help to improve the generalizability of AI.

CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma

Objectives

This study aimed to construct prediction models based on computerized tomography (CT) signs, histogram and morphology features for the diagnosis of micropapillary or solid (MIP/SOL) components of stage IA lung adenocarcinoma (LUAC) and to evaluate the models' performance.

Methods

This clinical retrospective study included image data of 376 patients with stage IA LUAC based on postoperative pathology, admitted to Putian First Hospital from January 2019 to June 2023. According to the presence of MIP/SOL components in postoperative pathology, patients were divided into MIP/SOL+ and MIP/SOL- groups. Cases with tumors ≤ 3 cm and ≤ 2 cm were separately analyzed. Each subgroup of patients was then randomly divided into a training set and a test set in a ratio of 7:3. The training set was used to build the prediction model, and the test set was used for internal validation.

Results

For tumors ≤ 3 cm, ground-glass opacity (GGO) [odds ratio (OR) = 0.244; 95% confidence interval (CI): 0.103-0.569; p = 0.001], entropy (OR = 1.748; 95% CI: 1.213-2.577; p = 0.004), average CT value (OR = 1.002; 95% CI: 1.000-1.004; p = 0.002), and kurtosis (OR = 1.240; 95% CI: 1.023-1.513; p = 0.030) were independent predictors of MIP/SOL components of stage IA LUAC. The area under the ROC curve (AUC) of the nomogram prediction model for predicting MIP/SOL components was 0.816 (95% CI: 0.756-0.877) in the training set and 0.789 (95% CI: 0.689-0.889) in the test set. In contrast, for tumors ≤ 2 cm, kurtosis was no longer an independent predictor. The nomogram prediction model had an AUC of 0.811 (95% CI: 0.731-0.891) in the training set and 0.833 (95% CI: 0.733-0.932) in the test set.

Conclusion

For tumors ≤ 3 cm and ≤ 2 cm, GGO, average CT value, and entropy were the same independent influencing factors in predicting MIP/SOL components of stage IA LUAC. The nomogram prediction models have potential diagnostic value for identifying MIP/SOL components of early-stage LUAC.

Evolving and Novel Applications of Artificial Intelligence in Thoracic Imaging

The advent of artificial intelligence (AI) is revolutionizing medicine, particularly radiology. With the development of newer models, AI applications are demonstrating improved performance and versatile utility in the clinical setting. Thoracic imaging is an area of profound interest, given the prevalence of chest imaging and the significant health implications of thoracic diseases. This review aims to highlight the promising applications of AI within thoracic imaging. It examines the role of AI, including its contributions to improving diagnostic evaluation and interpretation, enhancing workflow, and aiding in invasive procedures. Next, it further highlights the current challenges and limitations faced by AI, such as the necessity of 'big data', ethical and legal considerations, and bias in representation. Lastly, it explores the potential directions for the application of AI in thoracic radiology.

Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution

PURPOSE

The purpose of this study was to propose a deep learning-based approach to detect pulmonary embolism and quantify its severity using the Qanadli score and the right-to-left ventricle diameter (RV/LV) ratio on three-dimensional (3D) computed tomography pulmonary angiography (CTPA) examinations with limited annotations.

MATERIALS AND METHODS

Using a database of 3D CTPA examinations of 1268 patients with image-level annotations, and two other public datasets of CTPA examinations from 91 (CAD-PE) and 35 (FUME-PE) patients with pixel-level annotations, a pipeline consisting of: (i), detecting blood clots; (ii), performing PE-positive versus negative classification; (iii), estimating the Qanadli score; and (iv), predicting RV/LV diameter ratio was followed. The method was evaluated on a test set including 378 patients. The performance of PE classification and severity quantification was quantitatively assessed using an area under the curve (AUC) analysis for PE classification and a coefficient of determination (R²) for the Qanadli score and the RV/LV diameter ratio.

RESULTS

Quantitative evaluation led to an overall AUC of 0.870 (95% confidence interval [CI]: 0.850-0.900) for PE classification task on the training set and an AUC of 0.852 (95% CI: 0.810-0.890) on the test set. Regression analysis yielded R² value of 0.717 (95% CI: 0.668-0.760) and of 0.723 (95% CI: 0.668-0.766) for the Qanadli score and the RV/LV diameter ratio estimation, respectively on the test set.

CONCLUSION

This study shows the feasibility of utilizing AI-based assistance tools in detecting blood clots and estimating PE severity scores with 3D CTPA examinations. This is achieved by leveraging blood clots and cardiac segmentations. Further studies are needed to assess the effectiveness of these tools in clinical practice.

Scientific Status Quo of Small Renal Lesions: Diagnostic Assessment and Radiomics

Background: Small renal masses (SRMs) are defined as contrast-enhanced renal lesions less than or equal to 4 cm in maximal diameter, which can be compatible with stage T1a renal cell carcinomas (RCCs). Currently, 50-61% of all renal tumors are found incidentally. Methods: The characteristics of the lesion influence the choice of the type of management, which include several methods SRM of management, including nephrectomy, partial nephrectomy, ablation, observation, and also stereotactic body radiotherapy. Typical imaging methods available for differentiating benign from malignant renal lesions include ultrasound (US), contrast-enhanced ultrasound (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI). Results: Although ultrasound is the first imaging technique used to detect small renal lesions, it has several limitations. CT is the main and most widely used imaging technique for SRM characterization. The main advantages of MRI compared to CT are the better contrast resolution and tissue characterization, the use of functional imaging sequences, the possibility of performing the examination in patients allergic to iodine-containing contrast medium, and the absence of exposure to ionizing radiation. For a correct evaluation during imaging follow-up, it is necessary to use a reliable method for the assessment of renal lesions, represented by the Bosniak classification system. This classification was initially developed based on contrast-enhanced CT imaging findings, and the 2019 revision proposed the inclusion of MRI features; however, the latest classification has not yet received widespread validation. Conclusions: The use of radiomics in the evaluation of renal masses is an emerging and increasingly central field with several applications such as characterizing renal masses, distinguishing RCC subtypes, monitoring response to targeted therapeutic agents, and prognosis in a metastatic context.